Search Results - "Campbell, R Keith"

Clarifying the Role of Incretin-Based Therapies in the Treatment of Type 2 Diabetes Mellitus by Campbell, R. Keith, RPh, MBA, FASHP, CDE

“…Abstract Background Glucose homeostasis is the result of a complex interaction of a spectrum of hormones, including insulin, glucagon, amylin, and the…”
Get full text

Type 2 diabetes: Where we are today: An overview of disease burden, current treatments, and treatment strategies by Keith Campbell, R.

“…To provide an overview of the disease burden and current strategies in the treatment of patients with type 2 diabetes. Medline search of all relevant clinical…”
Get full text

Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus by Neumiller, Joshua J., Wood, Lindy, Campbell, R. Keith

“…Type 2 diabetes mellitus traditionally has been characterized by insulin resistance and β‐cell dysfunction, leading to hyperglycemia and eventual micro‐ and…”
Get full text

Fate of the beta-cell in the pathophysiology of type 2 diabetes by Keith Campbell, R.

“…To describe the progression of beta-cell dysfunction, now presumed to be the primary progenitor of type 2 diabetes, which appears early in the clinical course…”
Get full text

A Review of Inhaled Technosphere Insulin by Neumiller, Joshua J, Campbell, R Keith, Wood, Lindy D

“…Objective: To review the pharmacology, pharmacokinetics, efficacy, safety, and clinical use of Technosphere insulin. Data Sources: A MEDLINE search (1966–March…”
Get full text

Can a New Ultra-Long-Acting Insulin Analogue Improve Patient Care? Investigating the Potential Role of Insulin Degludec by Robinson, Jennifer D., Neumiller, Joshua J., Campbell, R. Keith

“…The basal-bolus concept of delivering insulin to diabetic patients makes physiological sense, as it mimics normal insulin release in people without diabetes…”
Get full text

Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus by Neumiller, Joshua J, Campbell, R Keith

“…The pharmacology, pharmacokinetics, efficacy, safety, and dosage and administration of saxagliptin are reviewed. Saxagliptin is a selective, reversible…”
Get full text

Exenatide: An incretin mimetic for the treatment of type 2 diabetes mellitus by Iltz, Jason L., Baker, Danial E., Setter, Stephen M., Keith Campbell, R.

“…Background: Exenatide is a subcutaneously injected incretin mimetic. It is indicated as adjunctive therapy to improve glycemic control in patients with type 2…”
Get full text

Etiology and effect on outcomes of hyperglycemia in hospitalized patients by Campbell, R Keith

“…The prevalence of diabetes in U.S. hospitals, etiology and pathophysiology of hyperglycemia in hospitalized patients, impact of hyperglycemia on patient…”
Get full text

Sodium-Glucose Co-Transport Inhibitors: Progress and Therapeutic Potential in Type 2 Diabetes Mellitus by Neumiller, Joshua J., White, John R., Campbell, R. Keith

“…The kidney plays a major role in glucose homeostasis because of its role in gluconeogenesis and the glomerular filtration and reabsorption of glucose in the…”
Get full text

Biochemical Pathways for Microvascular Complications of Diabetes Mellitus by Setter, Stephen M, Campbell, R Keith, Cahoon, Clifton J

“…OBJECTIVE: To review the current biochemical theories on how diabetes contributes to microvascular disease. DATA SOURCES: MEDLINE search (1980–June 2003) and…”
Get full text

Role of the pharmacist in diabetes management by Campbell, RK

“…The role of pharmacists in diabetes management, including patient identification, assessment, education, referral, and monitoring, is described. Pharmacists…”
Get full text

Type 2 diabetes: Epidemiology and treatment, pathophysiology, new therapeutics, and the evolving role of the pharmacist by Keith Campbell, R., Neumiller, Joshua J., White, John, Sisson, Evan, Kuhn, Catherine

Get full text

Recommendations for improving adherence to type 2 diabetes mellitus therapy--focus on optimizing insulin-based therapy by Campbell, R Keith

“…Despite its unsurpassed efficacy in the management of diabetes, insulin has been resisted and feared for its risk of side effects (ie, weight gain,…”
Get full text

Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus by Campbell, RK

“…OBJECTIVE: To review the clinical pharmacology data regarding the sulfonylurea glimepiride, and to summarize the clinical trials of glimepiride efficacy and…”
Get full text

Rationale for dipeptidyl peptidase 4 inhibitors : A new class of oral agents for the treatment of type 2 diabetes mellitus by CAMPBELL, R. Keith

“…To review advances in understanding the pathophysiologic basis of type 2 diabetes mellitus and the pharmacology and mechanism of action of dipeptidyl peptidase…”
Get full text

Liraglutide: A Once-Daily Incretin Mimetic for the Treatment of Type 2 Diabetes Mellitus by Neumiller, Joshua J, Campbell, R Keith

“…Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of liraglutide, a glucagon-like peptide 1 (GLP-1) analog for the treatment of…”
Get full text

Vitamin D and Diabetes by Martin, Teresa, Campbell, R. Keith

“…At high doses, vitamin D^sub 2^ may be less potent than vitamin D^sub 3^.37 The safe upper limit for vitamin D is 1,000-1,500 IU/day for infants, 2,500-3,000…”
Get full text

Diabetic neuropathy: an intensive review by Duby, JJ, Campbell, RK, Setter, SM, White, , JR, Rasmussen, KA

“…The epidemiology, classification, pathology, and treatment of diabetic neuropathy are reviewed. Diabetic peripheral neuropathy is a common complication of…”
Get full text

Pharmacotherapy of Diabetes: Past, Present, and Future: Preface by Campbell, R Keith

Get full text